Heli Lyytinen

1.1k total citations
25 papers, 621 citations indexed

About

Heli Lyytinen is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Heli Lyytinen has authored 25 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Oncology. Recurrent topics in Heli Lyytinen's work include Estrogen and related hormone effects (17 papers), Menopause: Health Impacts and Treatments (14 papers) and Cancer Risks and Factors (8 papers). Heli Lyytinen is often cited by papers focused on Estrogen and related hormone effects (17 papers), Menopause: Health Impacts and Treatments (14 papers) and Cancer Risks and Factors (8 papers). Heli Lyytinen collaborates with scholars based in Finland, Sweden and Norway. Heli Lyytinen's co-authors include ­Eero Pukkala, Olavi Ylikorkala, Olavi Ylikorkala, Tadeusz Dyba, Pauliina Tuomikoski, Tomi S. Mikkola, Pia Vattulainen, Fabian Hoti, Mika Gissler and Pasi Korhonen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Epidemiology and International Journal of Cancer.

In The Last Decade

Heli Lyytinen

24 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heli Lyytinen Finland 14 378 357 150 142 139 25 621
Tim Hillard United Kingdom 11 352 0.9× 351 1.0× 134 0.9× 154 1.1× 106 0.8× 31 760
Gambrell Rd United States 13 361 1.0× 311 0.9× 154 1.0× 183 1.3× 104 0.7× 27 672
R. Nachtigall United States 7 401 1.1× 382 1.1× 133 0.9× 71 0.5× 117 0.8× 11 673
Else Høibraaten Norway 9 229 0.6× 323 0.9× 36 0.2× 82 0.6× 32 0.2× 16 598
J. Robinson United Kingdom 10 146 0.4× 143 0.4× 57 0.4× 117 0.8× 39 0.3× 12 325
M J E Mourits Netherlands 8 185 0.5× 38 0.1× 143 1.0× 175 1.2× 57 0.4× 10 551
Åsa Ågren Sweden 9 147 0.4× 92 0.3× 86 0.6× 43 0.3× 83 0.6× 9 435
Antoine Bennet France 15 97 0.3× 388 1.1× 115 0.8× 135 1.0× 54 0.4× 38 743
Emmanuel Abu United Kingdom 11 106 0.3× 310 0.9× 143 1.0× 73 0.5× 35 0.3× 17 627
Haruo Tamaki Japan 15 96 0.3× 483 1.4× 30 0.2× 59 0.4× 91 0.7× 26 664

Countries citing papers authored by Heli Lyytinen

Since Specialization
Citations

This map shows the geographic impact of Heli Lyytinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heli Lyytinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heli Lyytinen more than expected).

Fields of papers citing papers by Heli Lyytinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heli Lyytinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heli Lyytinen. The network helps show where Heli Lyytinen may publish in the future.

Co-authorship network of co-authors of Heli Lyytinen

This figure shows the co-authorship network connecting the top 25 collaborators of Heli Lyytinen. A scholar is included among the top collaborators of Heli Lyytinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heli Lyytinen. Heli Lyytinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vehmanen, Leena, Heli Lyytinen, Hanna Savolainen‐Peltonen, et al.. (2024). Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. Breast Cancer Research and Treatment. 210(2). 295–305. 1 indexed citations
2.
3.
Botteri, Edoardo, Nathalie C. Støer, Elisabete Weiderpass, et al.. (2019). Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland. Cancer Epidemiology Biomarkers & Prevention. 28(11). 1857–1860. 15 indexed citations
4.
Mikkola, Tomi S., Pauliina Tuomikoski, Heli Lyytinen, et al.. (2016). Vaginal estradiol use and the risk for cardiovascular mortality. Human Reproduction. 31(4). 804–809. 19 indexed citations
5.
Tuomikoski, Pauliina, Veikko Salomaa, Aki S. Havulinna, et al.. (2016). Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use. Maturitas. 94. 106–109. 6 indexed citations
6.
Mikkola, Tomi S., Pauliina Tuomikoski, Heli Lyytinen, et al.. (2015). Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause The Journal of The North American Menopause Society. 22(9). 976–983. 77 indexed citations
7.
Tuomikoski, Pauliina, Heli Lyytinen, Pasi Korhonen, et al.. (2015). The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study. Maturitas. 81(3). 384–388. 5 indexed citations
8.
Mikkola, Tomi S., Pauliina Tuomikoski, Heli Lyytinen, et al.. (2015). Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy. The Journal of Clinical Endocrinology & Metabolism. 100(12). 4588–4594. 60 indexed citations
9.
Tuomikoski, Pauliina, Heli Lyytinen, Pasi Korhonen, et al.. (2014). Coronary Heart Disease Mortality and Hormone Therapy Before and After the Women's Health Initiative. Obstetrics and Gynecology. 124(5). 947–953. 23 indexed citations
10.
Korhonen, Katariina, Anssi Auvinen, Heli Lyytinen, Olavi Ylikorkala, & ­Eero Pukkala. (2012). A Nationwide Cohort Study on the Incidence of Meningioma in Women Using Postmenopausal Hormone Therapy in Finland. American Journal of Epidemiology. 175(4). 309–314. 31 indexed citations
11.
Riska, Annika, et al.. (2012). Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland. Gynecologic Oncology. 126(2). 241–244. 5 indexed citations
12.
Lyytinen, Heli, et al.. (2012). Ovarian cancer risk in postmenopausal women using estradiol–progestin therapy – a nationwide study. Climacteric. 16(1). 48–53. 17 indexed citations
13.
Lyytinen, Heli, et al.. (2011). Use of estradiol–progestin therapy associates with increased risk for uterine sarcomas. Gynecologic Oncology. 122(2). 260–263. 13 indexed citations
14.
Pukkala, ­Eero, et al.. (2011). Postmenopausal estradiol–progestagen therapy and risk for uterine cervical cancer. International Journal of Cancer. 131(4). E537–43. 19 indexed citations
15.
Lyytinen, Heli, et al.. (2010). Endometrial cancer associated with various forms of postmenopausal hormone therapy: A case control study. International Journal of Cancer. 128(7). 1644–1651. 40 indexed citations
16.
Lyytinen, Heli, et al.. (2009). Endometrial Cancer in Postmenopausal Women Using Estradiol–Progestin Therapy. Obstetrics and Gynecology. 114(6). 1197–1204. 40 indexed citations
17.
Lyytinen, Heli, Tadeusz Dyba, Olavi Ylikorkala, & ­Eero Pukkala. (2009). A case‐control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well. International Journal of Cancer. 126(2). 483–489. 73 indexed citations
18.
Lyytinen, Heli, Tadeusz Dyba, ­Eero Pukkala, & Olavi Ylikorkala. (2009). Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: National‐wide case‐control study from Finland. International Journal of Cancer. 127(1). 185–189. 12 indexed citations
19.
Lyytinen, Heli. (2009). A Nationwide Study on Breast Cancer Risk in Postmenopausal Women Using Hormone Therapy in Finland. Työväentutkimus Vuosikirja. 1 indexed citations
20.
Lyytinen, Heli, ­Eero Pukkala, & Olavi Ylikorkala. (2006). Breast Cancer Risk in Postmenopausal Women Using Estrogen-Only Therapy. Obstetrics and Gynecology. 108(6). 1354–1360. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Hillard Breakdown of academic impact, for papers by Gambrell Rd Breakdown of academic impact, for papers by R. Nachtigall Breakdown of academic impact, for papers by Else Høibraaten Breakdown of academic impact, for papers by J. Robinson Breakdown of academic impact, for papers by M J E Mourits Breakdown of academic impact, for papers by Åsa Ågren Breakdown of academic impact, for papers by Antoine Bennet Breakdown of academic impact, for papers by Emmanuel Abu Breakdown of academic impact, for papers by Haruo Tamaki
Rankless by CCL
2026